# Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI

> **NCT06490562** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 66 (estimated)

## Conditions studied

- Acute Graft-versus-host Disease

## Interventions

- **DRUG:** PDCy
- **DRUG:** Non Cy

## Key facts

- **NCT ID:** NCT06490562
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2028-05
- **Final completion:** 2028-12
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490562, "Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06490562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*